Thus, our work highlighted the significant role of the NSUN2–NRF2–YBX1 axis in regulating lung cancer cell ferroptosis and suggested its potential as a therapeutic target for NSCLC. Here, NFE2L2 is linked to non-small cell lung carcinoma.